Company:  ENZO BIOCHEM INC (ENZ)
Form Type:  PRE 14A
Filing Date:  1/6/2022 
CIK:  0000316253 
Address:  60 EXECUTIVE BLVD 
City, State, Zip:  FARMINGDALE, New York 11735 
Telephone:  (516) 755-5500 
Fiscal Year:  07/31 
Last Trade
Last Trade: 
$2.21  
Change: 
0.02 (0.91%)  
Trade Time: 
Jun 02  
Market Cap: 
$109.90M
Trade ENZ now with 

© 2023  
Description of Business
Enzo Biochem, Inc. (the "Company" "we", "our" or "Enzo") is an integrated diagnostics, clinical lab, and life sciences company focused on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable our customers to meet their clinical needs. We provide advanced biotechnology solutions to the global community as affordable and flexible quality products and services. We develop, manufacture and sell our proprietary technology solutions and platforms to clinical laboratories, specialty clinics, and researchers globally. Enzo's structure and business strategy represent the culmination of years of extensive planning and work. The Company has the unique ability to offer low cost, high performance products and services for diagnostic testing, which ideally positions us to capitalize on the reimbursement pressures facing diagnostic labs.
Register and access this filing in:     
  FORM PRE 14A
    NOTICE OF 2021 ANNUAL MEETING OF SHAREHOLDERS
    CARD ENCLOSED WITH THE ACCOMPANYING PROXY STATEMENT.
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
    PROPOSAL 1
    PROPOSAL 2
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
    AUDIT COMMITTEE REPORT
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    COMPENSATION OF DIRECTORS
    COMPENSATION OF EXECUTIVE OFFICERS
      COMPENSATION TABLE
    PROPOSAL 3
    PROPOSAL 4
    OTHER MATTERS
    ANNUAL REPORT
    SHAREHOLDER PROPOSALS


EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.